Colin S Brown

Has grant

Imperial College London
Country flagUnited Kingdom

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Pre-symptomatic asymptomatic MonkEypox (PRIME) study

Open Date: 2022-08-17

Close Date: 2023-03-17

Grant: Close

Pathogen Surveillance in Agriculture, Food and the Environment (PATH-SAFE)

Open Date: 2022-01-01

Close Date:

Grant: Close

Investigation of proven vaccine breakthrough by SARS-CoV-2 variants in established UK healthcare worker cohorts: SIREN consortium & PITCH Plus Pathway

Open Date: 2021-08-12

Close Date: 2022-08-11

Grant: Close

HCAI, Fungal, AMR, AMU, & Sepsis Division

Open Date: 2021-04-01

Close Date: 2022-03-01

Grant: Close

SIREN (Sarscov2 Immunity & REinfection EvaluatioN)

Open Date: 2020-06-01

Close Date: 2023-06-01

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Background Public health guidance recommending isolation of individuals with group A streptococcal (GAS) infection or carriage for 12–24 h from antibiotic initiation to prevent onward transmission requires a strong evidence base. Aim To estimate the pooled proportion of individuals who remain GAS culture-positive at set intervals after initiation of antibiotics through a systematic literature review (PROSPERO CRD42021290364) and meta-analysis. Methods We searched Ovid MEDLINE (1946–), EMBASE (1974–) and Cochrane library. We included interventional or observational studies with ≥ 10 participants reporting rates of GAS throat culture positivity during antibiotic treatment for culture-confirmed GAS pharyngitis, scarlet fever and asymptomatic pharyngeal GAS carriage. We did not apply age, language or geographical restrictions. Results Of 5,058 unique records, 43 were included (37 randomised controlled studies, three non-randomised controlled trials and three before-and-after studies). The proportion of individuals remaining culture-positive on day 1, day 2 and days 3–9 were 6.9% (95% CI: 2.7–16.8%), 5.4% (95% CI: 2.1–13.3%) and 2.6% (95% CI: 1.6–4.2%). For penicillins and cephalosporins, day 1 positivity was 6.5% (95% CI: 2.5–16.1%) and 1.6% (95% CI: 0.04–42.9%), respectively. Overall, for 9.1% (95% CI: 7.3–11.3), throat swabs collected after completion of therapy were GAS culture-positive. Only six studies had low risk of bias. Conclusions Our review provides evidence that antibiotics for pharyngeal GAS achieve a high rate of culture conversion within 24 h but highlights the need for further research given methodological limitations of published studies and imprecision of pooled estimates. Further evidence is needed for non-beta-lactam antibiotics and asymptomatic individuals.

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (15)

Yalda Jafari

-

CANADA
View details

Geraint Davies

Professor of Infection Pharmacology

University of Liverpool

UNITED KINGDOM
View details

Simon Collin

University of Bristol

UNITED KINGDOM
View details

Elaine Cloutman-Green

Honourary Professor

University College London

UNITED KINGDOM
View details

Shiranee Sriskandan

Prof

Imperial College London

UNITED KINGDOM
View details

William Welfare

Honorary Senior Clinical Lecturer

The University of Manchester

UNITED KINGDOM
View details

Theresa Lamagni

UK Health Security Agency

UNITED KINGDOM
View details

Eleri Sarah Wyn Wilson-Davies

University Hospital Southampton NHS Foundation Trust

UNITED KINGDOM
View details

Edward Monk

St George’s University Hospitals NHS Foundation Trust

UNITED KINGDOM
View details

David Simons

University College London

UNITED KINGDOM
View details

William Waites

University Of Strathclyde

UNITED KINGDOM
View details

Rebecca Guy

-

UNITED KINGDOM
View details

Andrew M. Edwards

Imperial College London

UNITED KINGDOM
View details

Brendan Payne

Honorary Clinical Senior Lecturer

Newcastle University

UNITED KINGDOM
View details

Hannah Higgins

UK Health Security Agency

UNITED KINGDOM
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.